Progress in research of long-term protective efficacy of human papillomavirus vaccine / 中华流行病学杂志
Chinese Journal of Epidemiology
;
(12): 851-854, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-985572
ABSTRACT
The efficacy of HPV vaccine in preventing cervical cancer has been demonstrated in numerous clinical trials and clinical uses. The follow-up after clinical trials usually last for 5-6 years to evaluate the long-term efficacy, and a series of long-term follow-up studies have been conducted in some regions. The literature retrieval of HPV vaccine long term efficiency research both at home and abroad indicated that the protective efficacy of the vaccine against vaccine-type-related cervical intraepithelial neoplasia grade 2 and above is higher than 90%.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Papillomaviridae
/
Investigación Biomédica
/
Vacunas contra Papillomavirus
Límite:
Humanos
Idioma:
Chino
Revista:
Chinese Journal of Epidemiology
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS